Massimo De Giorgio
Bergamo, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Durvalumab-Tremelimumab in Advanced Hepatocellular Carcinoma: Real-World Data From the LOR-HCC (Lombardy Real-World HCC Group).
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: January 24, 2026
RETREAT Score Accurately Predicts the Long-Term Risk of HCC Recurrence After Liver Transplantation: A Single-Center Real-Life Validation.
Journal: Cancers
Published: January 17, 2026
Outcomes of Y90-radioembolization as downstaging to liver transplantation in patients with hepatocellular carcinoma and tumoral portal vein thrombosis.
Journal: Hepatology (Baltimore, Md.)
Published: December 19, 2025
Long-term outcomes of Yttrium-90 transarterial radioembolization for patients with hepatocellular carcinoma.
Journal: European journal of nuclear medicine and molecular imaging
Published: December 16, 2024
Hepatotoxicity of Small Molecule Protein Kinase Inhibitors for Cancer.
Journal: Cancers
Published: February 21, 2023
Outcomes of Sorafenib for Recurrent Hepatocellular Carcinoma After Liver Transplantation in the Era of Combined and Sequential Treatments.
Journal: Transplantation
Published: August 22, 2022
Pre-Transplant Alpha-Fetoprotein > 25.5 and Its Dynamic on Waitlist Are Predictors of HCC Recurrence after Liver Transplantation for Patients Meeting Milan Criteria.
Journal: Cancers
Published: October 30, 2021
Regorafenib Efficacy After Sorafenib in Patients With Recurrent Hepatocellular Carcinoma After Liver Transplantation: A Retrospective Study.
Journal: Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
Published: February 19, 2021
Health status of patients with autoimmune liver disease during SARS-CoV-2 outbreak in northern Italy.
Journal: Journal of hepatology
Published: May 04, 2020
Liver transplantation in hepatocellular carcinoma after tumour downstaging (XXL): a randomised, controlled, phase 2b/3 trial.
Journal: The Lancet. Oncology
Published: September 20, 2019
Treatment of hepatocellular carcinoma: a cost analysis of yttrium-90 transarterial radioembolization versus sorafenib.
Journal: Future oncology (London, England)
Published: March 27, 2018
Last Updated: 09/26/2026